| 000 | 01714 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515105730.0 | ||
| 264 | 0 | _c20090309 | |
| 008 | 200903s 0 0 eng d | ||
| 022 | _a1525-1438 | ||
| 024 | 7 |
_a10.1111/j.1525-1438.2007.01181.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSingh, P | |
| 245 | 0 | 0 |
_aSerous carcinoma of the uterus-determination of HER-2/neu status using immunohistochemistry, chromogenic in situ hybridization, and quantitative polymerase chain reaction techniques: its significance and clinical correlation. _h[electronic resource] |
| 260 |
_bInternational journal of gynecological cancer : official journal of the International Gynecological Cancer Society _c |
||
| 300 |
_a1344-51 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aIn Situ Hybridization |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 | _aProto-Oncogene Mas |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xgenetics |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aUterine Neoplasms _xgenetics |
| 700 | 1 | _aSmith, C L | |
| 700 | 1 | _aCheetham, G | |
| 700 | 1 | _aDodd, T J | |
| 700 | 1 | _aDavy, M L J | |
| 773 | 0 |
_tInternational journal of gynecological cancer : official journal of the International Gynecological Cancer Society _gvol. 18 _gno. 6 _gp. 1344-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1525-1438.2007.01181.x _zAvailable from publisher's website |
| 999 |
_c17754217 _d17754217 |
||